• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Frederick C. Wang, MD


  • Wang F, Arun P, Friedman J, Chen Z, Van Waes C.Current and potential inflammation targeted therapies in head and neck cancer.Curr Opin Pharmacol. 2009 Aug;9(4):389-95. Review.
  • Fogg MH,Wirth LJ,Posner M,Wang F.Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3318-23.
  • Chen A, Zhao B, Kieff E, Aster JC, Wang F.EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.J Virol. 2006 Oct;80(20):10139-50.
  • Li J, Wang F, Mamon H, Kulke MH, Harris L, Maher E, Wang L, Makrigiorgos GM.Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples.Clin Chem. 2006 Apr;52(4):624-33.
  • Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, Neuberg DS, Bollag G, Shipp MA, Aguiar RC.The phosphodiesterase PDE4B limits cAMP associated, PI3K-AKT dependent, apoptosis in diffuse large B-cell lymphoma.Blood. 2005 Jan 1;105(1):308-16.
  • Rivailler P, Cho YG, Wang F.Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.J Virol. 2002 Dec;76(23):12055-68.
  • Schmidtko J, Wang R, Wu CL, Mauiyyedi S, Harris NL, Della Pelle P, Brousaides N, Zagachin L, Ferry JA, Wang F, Kawai T, Sachs DH, Cosimi BA, Colvin RB.Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys.Transplantation. 2002 May 15;73(9):1431-9.
  • Rivailler P, Jiang H, Cho YG, Quink C, Wang F.Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.J Virol. 2002 Jan;76(1):421-6.
  • Cho Y, Ramer J, Rivailler P, Quink C, Garber RL, Beier DR, Wang F.An Epstein-Barr-related herpesvirus from marmoset lymphomas.Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1224-9.
  • Cho YG, Gordadze AV, Ling PD, Wang F.Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.J Virol. 1999 Nov;73(11):9206-12.
  • Blake NW, Moghaddam A, Rao P, Kaur A, Glickman R, Cho YG, Marchini A, Haigh T, Johnson RP, Rickinson AB, Wang F.Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.J Virol. 1999 Sep;73(9):7381-9.
  • Ridker PM, Hennekens CH, Stampfer MJ, Wang F.Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.Circulation. 1998 Dec 22-29;98(25):2796-9.
  • Moghaddam A, Rosenzweig M, Lee-Parritz D, Annis B, Johnson RP, Wang F.An animal model for acute and persistent Epstein-Barr virus infection.Science. 1997 Jun 27;276(5321):2030-3.
  • Franken M, Estabrooks A, Cavacini L, Sherburne B, Wang F, Scadden DT.Epstein-Barr virus-driven gene therapy for EBV-related lymphomas.Nat Med. 1996 Dec;2(12):1379-82.